Product portfolio

Donor Screening - Nucleic Acid Testing (NAT)

Over 60 million blood and plasma donations were tested on Roche NAT systems each day.

From launching the first Nucleic Acid Testing assays for blood screening, Roche has consistently remained in the forefront in keeping the blood supply safe through active surveillance of emerging infections and through rapid development of screening solutions.

Roche NAT instruments, assays and reagents have been developed using the gold standard real-time Polymerase Chain Reaction (PCR) technology, a very sensitive and high-performing technology that detects DNA and RNA molecules of infectious agents such as HIV/HCV/HBV at an early stage of an infection. Easily integrated into pre- and post-analytic solutions they enable donor screening facilities to fully automate operations, boost throughput and achieve quicker turnaround times - leading to greater overall workflow efficiency.

Roche’s state-of-the-art NAT assays provide comprehensive genotype coverage and excellent sensitivity.  Together with analyzers that provide efficient workflows, they deliver fast results. Roche’s leading molecular diagnostic solutions deliver predictable operational outcomes for laboratories and help reduce the risk of disease transmission and adverse health effects in patients. 

 

View all products

Related systems

Product image for cobas® 6800/8800 Systems
Product image for cobas® 6800/8800 Systems
Product image for cobas® S 201

 

Explore Roche NAT assays and analyzers for donor screening

Comprehensive Nucleic Acid Testing menu for blood and plasma screening

 

  • cobas® MPX  
HIV-1 Group M, HIV-1 Group O, HIV-2, HCV and HBV
  • cobas® WNV 
West Nile virus
  • cobas® DPX
B19V and HAV
  • cobas® Zika
Zika virus
  • cobas® Babesia
Babesia parasite

 

Assays for use with the cobas s 201 system

  • cobas® TaqScreen MPX 2.0
HIV-1 Group M, HIV-1 Group O, HIV-2, HCV and HBV
  • cobas® TaqScreen WNV
West Nile virus
  • cobas® TaqScreen DPX
B19V and HAV
Which NAT solution best fits your needs?
cobass 201
cobas s 201 system

Reliability meets modular automation - the first multi-dye, nucleic acid amplification technology for blood and plasma.

See more

cobas 6800 system

cobas® 6800 System

  • Mid to high volume workload
  • Throughput of up to 384 tests in an 8-hour shift - 1,536 tests in 24 hours - with only 3 user interactions per run
  • Up to 8 hours of walk-away time*
See more

* May vary based on workflow demands

cobas 8800

cobas® 8800 System

  • High to extra high volume workload
  • Throughput of up to 960 tests in an 8-hour shift - 4,032 tests in 24 hours - with only 3 user interactions per run
  • Up to 4 hours of walk-away time*
See more

* May vary based on workflow demands

 

Designed to work together

cobas® 6800 System

Transform your testing experience for IVD applications—just 2 simple user interactions per run and up to 8 hours of walk-away time.

More

cobas® 8800 System

Unparalleled performance with minimal operator interaction revolutionizes the future of high-throughput applications. 

More

cobas s 201 system

Discover efficiency, reliability and modular automation in the first multi-dye, nucleic acid amplification technology for blood and plasma.

More

*Products of the Roche Blood Safety Solutions portfolio are not commercially available in all regions. Please contact your local Roche representative regarding availability.

References

  1. Data on file.

References: 

1. Roche Molecular Systems internal customer data base 2015.

Nucleic Acid Testing products
Found 0 results in
Filters
...
    ...